Website profile

Stock Titan

Elevate your trading with Stock Titan's AI-powered tools. Get real-time stock news, AI insights, momentum scanner, and more. Make informed decisions on NYSE, NASDAQ, and OTC markets with our advanced investing platform.

  • 28,693articles · 365d
  • 6+ day agolatest article
  • Sep 13, 2025earliest in window
  • 91%with images
  • 260avg words
articles per day
Categories
  • Economy, Business & Finance 25,606
  • Finance & Business 22,044
  • News 14,158
  • Business & Industrial 4,903
  • Finance 3,706
  • Health & Wellness 2,036
  • Industrial 1,954
  • Medical 1,565

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Stock Titan
stocktitan.net > news > WNFT > worldwide-nft-inc-announces-change-of-control-52prjp3mffy4.html

M&A veteran Jay Wright takes control of debt-free Worldwide NFT

3+ mon, 3+ week ago   (669+ words) Stock Titan - Worldwide NFT, Inc. Announces Change of Control, Recapitalization Worldwide NFT (OTC: WNFTD; WNFT) announced a change of control and recapitalization. Jay Wright has acquired majority voting control from George Sharp, effective immediately. Wright brings extensive M&A, public-company…...

@StockTitan_net
stocktitan.net > sec-filings > TCRT > 8-k-alaunos-therapeutics-inc-reports-material-event-64742fe55aaf.html

Alaunos (Nasdaq: TCRT) shows ALN1003 obesity data, reports $0.354M cash

3+ mon, 3+ week ago   (569+ words) Brand Engagement Network Reports Strongest Quarter to Date Encouraging preclinical signals are overshadowed by a very short cash runway. Alaunos presents non-GLP mouse data suggesting ALN1003 may affect insulin-resistance biomarkers, adipose endocrine signaling, and liver steatosis markers in diet-induced obesity models....

Stock Titan
stocktitan.net > news > CGEN > compugen-reports-first-quarter-2026-d9kqey9uojzz.html

Compugen cancer trials, AstraZeneca and Gilead deals, cash runway into 2029

4+ mon, 23+ hour ago   (588+ words) Brand Engagement Network Reports Strongest Quarter to Date Compugen (NASDAQ:CGEN) reported Q1 2026 results and clinical progress. Cash, cash equivalents, deposits and securities totaled $134.9 million as of March 31, 2026, with no debt and cash runway expected to fund operations into 2029. Following this…...

Stock Titan
stocktitan.net > news > MRT > marti-technologies-inc-to-report-2026-first-quarter-results-on-may-unuzddvfftzg.html

Mobility super app Marti sets May 21 call on Q1 2026 results

3+ mon, 3+ week ago   (127+ words) Baidu Announces First Quarter 2026 Results Interim Report Q1 January - March 2026 ISTANBUL--(BUSINESS WIRE)-- Marti Technologies, Inc. (“Marti”) (NYSE American: MRT), Türkiye’s leading mobility super app, will announce its financial and operational results for the quarter ended March 31, 2026 (“2026 First Quarter Results”) before…...

Stock Titan
stocktitan.net > news > IQ > i-qiyi-announces-first-quarter-2026-financial-x6ptc5l4zmq2.html

iQIYI posts Q1 loss, proposes Hong Kong listing and $100M buyback

5+ mon, 3+ week ago   (764+ words) Revenue fell 13% to RMB6.23B as iQIYI swung from RMB182M profit to RMB295M net loss and repurchased $207.8M of 2028 notes plus 6.5M ADSs under a $100M plan....

Google News
stocktitan.net > news > NIU > niu-technologies-announces-unaudited-first-quarter-2026-financial-f413dhsorxpf.html

Niu Technologies Q1 revenue up 33%, loss widens | NIU Stock News

4+ mon, 3+ week ago   (884+ words) Interim Report Q1 January - March 2026 SOHU.COM REPORTS FIRST QUARTER 2026 UNAUDITED FINANCIAL RESULTS Niu Technologies (NASDAQ: NIU) reported unaudited Q1 2026 revenues of RMB 909.5 million, up 33.4% year over year. Total e-scooter sales rose 28.7% to 261,624 units, driven by 35.4% growth in China, while international units…...

Google News
stocktitan.net > news > FCN > compass-lexecon-adds-leading-competition-and-regulatory-economist-in-6fifgugt6zgu.html

FTI Consulting's Compass Lexecon hires EVP Mazzarotto | FCN Stock News

4+ mon, 1+ week ago   (423+ words) Interim Report Q1 January - March 2026 SOHU.COM REPORTS FIRST QUARTER 2026 UNAUDITED FINANCIAL RESULTS FTI Consulting (NYSE: FCN) subsidiary Compass Lexecon appointed Nicola Mazzarotto as Executive Vice President in London on May 18, 2026. He brings more than 26 years of competition and regulatory economics…...

Stock Titan
stocktitan.net > news > SOHU > sohu-com-reports-first-quarter-2026-unaudited-financial-ow78aa7grd8k.html

Sohu.com's $141M quarter ends in $4M loss, with $1.2B cash

4+ mon, 5+ day ago   (1070+ words) AVITA Medical to Host Investor Webinar Briefing Sohu (NASDAQ: SOHU) reported Q1 2026 revenues of US$141 million, up 4% year-over-year and down 1% quarter-over-quarter. Online game revenues were US$125 million, up 6% year-over-year and 3% quarter-over-quarter, while marketing services revenues were US$13 million, down 8% year-over-year. GAAP…...

Stock Titan
stocktitan.net > news > GOGO > gogo-announces-first-quarter-jg1wda9r4g4c.html

Gogo sold a record 511 air-to-ground units as revenue fell 2%

4+ mon, 5+ day ago   (556+ words) Celsius Holdings Reports First Quarter 2026 Financial Results Shell plc publishes first quarter 2026 press release Shell Plc 1st Quarter 2026 Unaudited Results Shell announces commencement of a share buyback programme Gogo (NASDAQ: GOGO) reported Q1 2026 results: Total revenue $226.3M (down 2% YoY), equipment revenue $38.6M (up 22% YoY),…...

@StockTitan_net
stocktitan.net > sec-filings > ARGX > 6-k-argenx-se-current-report-foreign-issuer-adc1c9a14ce8.html

argenx (NASDAQ: ARGX) posts $1.3B Q1 2026 sales with 63% growth and stronger profit

4+ mon, 5+ day ago   (220+ words) Celsius Holdings Reports First Quarter 2026 Financial Results Datadog Announces First Quarter 2026 Financial Results Profit for the period more than doubled to $366 million from $169 million, with basic earnings of $5.90 per share versus $2.78 a year earlier. Cash, cash equivalents and current financial…...